NLRP3 and Alzheimer disease: Ising (45) demonstrated that activation of the NLRP3 inflammasome in microglia accelerates tau pathology and cognitive impairment in an AD mouse model, providing direct evidence that innate immune activation contributes to neurodegeneration through inflammasome signaling.